Published in Int Orthop on November 18, 2010
First experiences with negative pressure wound therapy and instillation in the treatment of infected orthopaedic implants: a clinical observational study. Int Orthop (2011) 1.14
Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature. Clin Orthop Relat Res (2013) 1.07
Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop (2013) 1.01
Retention treatment after periprosthetic total hip arthroplasty infection. Int Orthop (2011) 1.01
Sonication of antibiotic-loaded cement spacers in a two-stage revision protocol for infected joint arthroplasty. BMC Musculoskelet Disord (2013) 0.99
Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: When is the best time to perform the second stage? Int Orthop (2015) 0.94
Decreased bacteria activity on Si₃N₄ surfaces compared with PEEK or titanium. Int J Nanomedicine (2012) 0.93
Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating. ACS Appl Mater Interfaces (2012) 0.93
Clinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitis. Bone Joint Res (2014) 0.91
Routine one-stage exchange for chronic infection after total hip replacement. Int Orthop (2014) 0.84
Surgical treatment approaches and reimbursement costs of surgical site infections post hip arthroplasty in Australia: a retrospective analysis. BMC Health Serv Res (2013) 0.84
Revision in cemented and cementless infected hip arthroplasty. Open Orthop J (2013) 0.84
Total Hip Arthroplasty, state of the art for the 21st century. Int Orthop (2011) 0.82
Towards an understanding of the painful total knee: what is the role of patient biology? Curr Rev Musculoskelet Med (2016) 0.82
The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections. Knee Surg Sports Traumatol Arthrosc (2015) 0.79
Vancomycin containing PLLA/β-TCP controls MRSA in vitro. Clin Orthop Relat Res (2011) 0.79
Primary total hip arthroplasty: health related quality of life outcomes. Int Orthop (2013) 0.77
Managing uncertainty - a qualitative study of surgeons' decision-making for one-stage and two-stage revision surgery for prosthetic hip joint infection. BMC Musculoskelet Disord (2017) 0.75
Efficacy of Debridement for Early Periprosthetic Joint Infection after Hip Arthroplasty. Hip Pelvis (2014) 0.75
Management of Periprosthetic Hip Joint Infection. Hip Pelvis (2015) 0.75
Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty. Open Orthop J (2016) 0.75
Vancomycin-Resistant Pseudomonas Aeroginosa in the Cases of Trauma. Med Arch (2016) 0.75
What are the risk factors for post-operative infection after hip hemiarthroplasty? Systematic review of literature. Int Orthop (2015) 0.75
Short-interval two-stage approach to primary total knee arthroplasty for acutely septic osteoarthritic knees. Knee Surg Sports Traumatol Arthrosc (2016) 0.75
Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am (1996) 3.73
Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am (1995) 2.83
Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother (2003) 1.92
A cement spacer for two-stage revision of infected implants of the hip joint. Int Orthop (1998) 1.83
Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty (2007) 1.77
One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother (2009) 1.74
Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am (2004) 1.63
Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res (2000) 1.54
The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br (2006) 1.53
Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty (2001) 1.51
Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty (1996) 1.48
Successful treatment of total hip and knee infection with articulating antibiotic components: a modified treatment method. Clin Orthop Relat Res (2004) 1.42
The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty (1997) 1.42
Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res (1994) 1.40
Treatment of infected retained implants. J Bone Joint Surg Br (2005) 1.39
Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic-loaded cement spacer. Clinics (Sao Paulo) (2007) 1.32
Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect (2006) 1.28
The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br (2008) 1.26
A two-stage retention débridement protocol for acute periprosthetic joint infections. Clin Orthop Relat Res (2010) 1.25
One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br (2008) 1.24
Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty (2005) 1.20
Treatment of deep infection of the hip associated with massive bone loss: two-stage revision with an antibiotic-loaded interim cement prosthesis followed by reconstruction with allograft. J Bone Joint Surg Br (2005) 1.19
Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci (2009) 1.19
Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res (2008) 1.18
Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br (2009) 1.16
Cementless two-staged total hip arthroplasty for deep periprosthetic infection. Clin Orthop Relat Res (2005) 1.14
One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop (2008) 1.11
The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg Am (1994) 1.10
Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br (2005) 1.08
Treatment of an infected total hip replacement with the PROSTALAC system. Part 1: Infection resolution. Can J Surg (2007) 1.07
Infected Total Hip Arthroplasty: Diagnosis and Treatment. J Am Acad Orthop Surg (1995) 1.07
One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty (2008) 1.07
Comparison of the results of the Girdlestone pseudarthrosis with reimplantation of a total hip replacement. Int Orthop (1998) 1.07
Liquid gentamicin in bone cement: a laboratory study of a potentially more cost-effective cement spacer. J Bone Joint Surg Am (2005) 1.03
Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy. J Antimicrob Chemother (2009) 1.03
Long-stem versus short-stem preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Hip Int (2010) 0.98
Antimicrobial properties and elution kinetics of linezolid-loaded hip spacers in vitro. J Biomed Mater Res B Appl Biomater (2008) 0.96
Treatment of infections occurring in total hip surgery. Orthop Clin North Am (1975) 0.94
Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty (2008) 0.93
Retracted Cement spacer loaded with antibiotics for infected implants of the hip joint. J Arthroplasty (2007) 0.91
Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clin Orthop Relat Res (1994) 0.91
Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics. Arch Orthop Trauma Surg (2008) 0.86
Two-stage operative strategy without local antibiotic treatment for infected hip arthroplasty: clinical and radiological outcome. Arch Orthop Trauma Surg (2006) 0.86
Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action. Chir Organi Mov (2008) 0.81
The use of sparse CT datasets for auto-generating accurate FE models of the femur and pelvis. J Biomech (2006) 1.07
Functional outcome of femoral peri prosthetic fracture and revision hip arthroplasty: a matched-pair study from the New Zealand Registry. Acta Orthop (2008) 1.01
Quantitative CT-assisted osteodensitometry of femoral adaptive bone remodelling after uncemented total hip arthroplasty. Int Orthop (2007) 0.97
Clinical faceoff: Ceramic-on-ceramic THA: do the advantages outweigh the limitations? Clin Orthop Relat Res (2014) 0.93
Osteodensitometry after total hip replacement with uncemented taper-design stem. Int Orthop (2003) 0.91
Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease. J Clin Endocrinol Metab (2008) 0.91
Loss of tibial bone density in patients with rotating- or fixed-platform TKA. Clin Orthop Relat Res (2009) 0.90
Absence of somatic SQSTM1 mutations in Paget's disease of bone. J Clin Endocrinol Metab (2008) 0.90
An ABJS Best Paper: Progressive cancellous and cortical bone remodeling after press-fit cup fixation: a 3-year followup. Clin Orthop Relat Res (2007) 0.89
Clinical outcome and periprosthetic bone remodelling of an uncemented femoral component with taper design. Int Orthop (2003) 0.88
Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res (2007) 0.88
Development and validation of patient-specific finite element models of the hemipelvis generated from a sparse CT data set. J Biomech Eng (2008) 0.86
Associated lesions in posterior wall acetabular fractures: not a valid predictor of failure. J Orthop Traumatol (2013) 0.83
Periprosthetic femoral fractures after total hip arthroplasty. ANZ J Surg (2007) 0.82
Proximal tibial bone density is preserved after unicompartmental knee arthroplasty. Clin Orthop Relat Res (2013) 0.82
Retroacetabular stress-shielding in THA. Clin Orthop Relat Res (2008) 0.82
Osteomyelitis in Polynesian children. Int Orthop (2004) 0.81
Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study. Clin Orthop Relat Res (2008) 0.81
Quantitative CT with finite element analysis: towards a predictive tool for bone remodelling around an uncemented tapered stem. Int Orthop (2012) 0.80
Fat and bone marrow embolism during percutaneous vertebroplasty. Anesth Analg (2003) 0.75
Skin infections of the limbs of Polynesian children. N Z Med J (2004) 0.75
Validation of an efficient method of assigning material properties in finite element analysis of pelvic bone. Comput Methods Biomech Biomed Engin (2014) 0.75
Altered load transfer in the pelvis in the presence of periprosthetic osteolysis. J Biomech Eng (2014) 0.75
Human Spinal Bone Dust as a Potential Local Autograft: In vitro Potent Anabolic Effect on Human Osteoblasts. Spine (Phila Pa 1976) (2017) 0.75
Computer-assisted osteodensitometry following total hip arthroplasty. Expert Rev Med Devices (2006) 0.75
[Analysis of the periprosthetic femoral bone reaction after uncemented total hip arthroplasty with computertomography assisted osteodensitometry in vivo: 6-year follow-up]. Biomed Tech (Berl) (2006) 0.75